Nutex Health (NUTX) to Release Quarterly Earnings on Thursday

Nutex Health (NASDAQ:NUTX) is set to release its earnings data after the market closes on Thursday, November 7th.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.22. Nutex Health had a negative return on equity of 43.79% and a negative net margin of 13.73%. The business had revenue of $76.08 million for the quarter.

Nutex Health Price Performance

NASDAQ NUTX traded up $1.48 during mid-day trading on Tuesday, hitting $24.52. The stock had a trading volume of 20,144 shares, compared to its average volume of 40,368. The company has a 50 day simple moving average of $22.05 and a 200 day simple moving average of $12.85. The company has a market cap of $124.32 million, a price-to-earnings ratio of -2.67 and a beta of 0.11. Nutex Health has a 52-week low of $4.16 and a 52-week high of $42.77. The company has a quick ratio of 1.55, a current ratio of 1.59 and a debt-to-equity ratio of 3.04.

Insiders Place Their Bets

In related news, CFO Jon Christian Bates acquired 1,350 shares of Nutex Health stock in a transaction dated Thursday, August 22nd. The shares were acquired at an average cost of $21.46 per share, for a total transaction of $28,971.00. Following the completion of the transaction, the chief financial officer now directly owns 2,277 shares of the company’s stock, valued at $48,864.42. The trade was a 100.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 38.52% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

NUTX has been the subject of several research reports. Benchmark lifted their price target on Nutex Health from $30.00 to $45.00 and gave the stock a “buy” rating in a research note on Wednesday, August 21st. Maxim Group began coverage on shares of Nutex Health in a research report on Wednesday, September 18th. They set a “buy” rating and a $45.00 target price for the company.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.